Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
ARA-290 received FDA Orphan Drug Designation for this indication TRPV1-mediated pain models ARA-290 demonstrated specific inhibition of TRPV1 channel activity, relieving capsaicin-induced mechanical hypersensitivity in pre-clinical nociceptor models Complex Regional Pain Syndrome (CRPS) investigational studies have examined ARA-290 in CRPS models due to its dual anti-inflammatory and nociceptor-targeting mechanism Chronic neuropathic pain multiple studies confirm ARA-290 reduces neuroinflammation in the spinal cord by suppressing TNF-, IL-1, and other pro-inflammatory cytokines that maintain chronic pain states Neuroprotection and CNS Research: Cerebral ischaemia/stroke models Wang et al
The way you get that B-12 matters just as much as how much you take
Elevates oxygen-consumption rates in Seahorse and high-resolution respirometry protocols, enabling precise measurement of electron-transport-chain efficiency
Available: [6] C.-H
Mild injection-site discomfort can happen after some injections
Testosterone cypionate - Use in pregnancy
US$ 21.81
US$ 23.14
US$ 20.60
US$ 25.86
US$ 28.99
US$ 29.88
US$ 25.16
US$ 27.56
US$ 24.85
US$ 25.58
US$ 26.77
